Bevacizumab-Containing Chemoimmunotherapy for Recurrent Non-Small-Cell Lung Cancer after Chemoradiotherapy: Case Report

Chemoimmunotherapy has become the standard of care as the first-line treatment of advanced or recurrent non-small-cell lung cancer (NSCLC). The bevacizumab-containing chemoimmunotherapy regimen is theoretically more effective than a non-bevacizumab-containing regimen via two mechanisms: a superior o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medicina (Kaunas)
Asıl Yazarlar: Kataoka, Nobutaka, Kunimatsu, Yusuke, Tsutsumi, Rei, Tani, Nozomi, Sato, Izumi, Tanimura, Mai, Nakano, Takayuki, Tanimura, Keiko, Kato, Daishiro, Takeda, Takayuki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2021
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8226573/
https://ncbi.nlm.nih.gov/pubmed/34072448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina57060547
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller